Home > > > > Report Detail

Global Influenza Vaccine Market Growth 2020-2025

Publisher Name :
Date: 27-Aug-2020
No. of pages: 130

According to this study, over the next five years the Influenza Vaccine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Influenza Vaccine, covering the supply chain analysis, impact assessment to the Influenza Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Influenza Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Whole Virus Vaccines

- Split Virus Vaccines

- Subunit Vaccines

- Live Attenuated Virus Vaccines

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- CSL

- GSK

- Mylan

- AstraZeneca

- Sanofi Pasteur

- Pfizer

- Johnson & Johnson

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Influenza Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Influenza Vaccine market by identifying its various subsegments.

- Focuses on the key global Influenza Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Influenza Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Influenza Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Influenza Vaccine Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Vaccine Consumption 2015-2025
2.1.2 Influenza Vaccine Consumption CAGR by Region
2.2 Influenza Vaccine Segment by Type
2.2.1 Whole Virus Vaccines
2.2.2 Split Virus Vaccines
2.2.3 Subunit Vaccines
2.2.4 Live Attenuated Virus Vaccines
2.3 Influenza Vaccine Consumption by Type
2.3.1 Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Influenza Vaccine Sale Price by Type (2015-2020)
2.4 Influenza Vaccine Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Influenza Vaccine Consumption by Application
2.5.1 Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Influenza Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Influenza Vaccine Sale Price by Type (2015-2020)

3 Global Influenza Vaccine by Company
3.1 Global Influenza Vaccine Sales Market Share by Company
3.1.1 Global Influenza Vaccine Sales by Company (2018-2020)
3.1.2 Global Influenza Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Influenza Vaccine Revenue Market Share by Company
3.2.1 Global Influenza Vaccine Revenue by Company (2018-2020)
3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Influenza Vaccine Sale Price by Company
3.4 Global Influenza Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Influenza Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Influenza Vaccine by Regions
4.1 Influenza Vaccine by Regions
4.2 Americas Influenza Vaccine Consumption Growth
4.3 APAC Influenza Vaccine Consumption Growth
4.4 Europe Influenza Vaccine Consumption Growth
4.5 Middle East & Africa Influenza Vaccine Consumption Growth

5 Americas
5.1 Americas Influenza Vaccine Consumption by Countries
5.1.1 Americas Influenza Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Influenza Vaccine Value by Countries (2015-2020)
5.2 Americas Influenza Vaccine Consumption by Type
5.3 Americas Influenza Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Influenza Vaccine Consumption by Regions
6.1.1 APAC Influenza Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Influenza Vaccine Value by Regions (2015-2020)
6.2 APAC Influenza Vaccine Consumption by Type
6.3 APAC Influenza Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Influenza Vaccine by Countries
7.1.1 Europe Influenza Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Influenza Vaccine Value by Countries (2015-2020)
7.2 Europe Influenza Vaccine Consumption by Type
7.3 Europe Influenza Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Influenza Vaccine by Countries
8.1.1 Middle East & Africa Influenza Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Influenza Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Influenza Vaccine Consumption by Type
8.3 Middle East & Africa Influenza Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Influenza Vaccine Distributors
10.3 Influenza Vaccine Customer

11 Global Influenza Vaccine Market Forecast
11.1 Global Influenza Vaccine Consumption Forecast (2021-2025)
11.2 Global Influenza Vaccine Forecast by Regions
11.2.1 Global Influenza Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Influenza Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Vaccine Forecast by Type
11.8 Global Influenza Vaccine Forecast by Application

12 Key Players Analysis
12.1 CSL
12.1.1 Company Information
12.1.2 Influenza Vaccine Product Offered
12.1.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Influenza Vaccine Product Offered
12.2.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Mylan
12.3.1 Company Information
12.3.2 Influenza Vaccine Product Offered
12.3.3 Mylan Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Latest Developments
12.4 AstraZeneca
12.4.1 Company Information
12.4.2 Influenza Vaccine Product Offered
12.4.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 AstraZeneca Latest Developments
12.5 Sanofi Pasteur
12.5.1 Company Information
12.5.2 Influenza Vaccine Product Offered
12.5.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sanofi Pasteur Latest Developments
12.6 Pfizer
12.6.1 Company Information
12.6.2 Influenza Vaccine Product Offered
12.6.3 Pfizer Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Johnson & Johnson
12.7.1 Company Information
12.7.2 Influenza Vaccine Product Offered
12.7.3 Johnson & Johnson Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Johnson & Johnson Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Influenza Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Whole Virus Vaccines
Table 5. Major Players of Split Virus Vaccines
Table 6. Major Players of Subunit Vaccines
Table 7. Major Players of Live Attenuated Virus Vaccines
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
Table 10. Global Influenza Vaccine Revenue by Type (2015-2020) ($ million)
Table 11. Global Influenza Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Influenza Vaccine Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Influenza Vaccine Consumption Market Share by Application (2015-2020)
Table 15. Global Influenza Vaccine Value by Application (2015-2020)
Table 16. Global Influenza Vaccine Value Market Share by Application (2015-2020)
Table 17. Global Influenza Vaccine Sale Price by Application (2015-2020)
Table 18. Global Influenza Vaccine Sales by Company (2017-2019) (K Doses)
Table 19. Global Influenza Vaccine Sales Market Share by Company (2017-2019)
Table 20. Global Influenza Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Influenza Vaccine Revenue Market Share by Company (2017-2019)
Table 22. Global Influenza Vaccine Sale Price by Company (2017-2019)
Table 23. Global Influenza Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Influenza Vaccine Products Offered
Table 25. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Influenza Vaccine Consumption by Regions 2015-2020 (K Doses)
Table 27. Global Influenza Vaccine Consumption Market Share by Regions 2015-2020
Table 28. Global Influenza Vaccine Value by Regions 2015-2020 ($ Millions)
Table 29. Global Influenza Vaccine Value Market Share by Regions 2015-2020
Table 30. Americas Influenza Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 31. Americas Influenza Vaccine Consumption Market Share by Countries (2015-2020)
Table 32. Americas Influenza Vaccine Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Influenza Vaccine Value Market Share by Countries (2015-2020)
Table 34. Americas Influenza Vaccine Consumption by Type (2015-2020) (K Doses)
Table 35. Americas Influenza Vaccine Consumption Market Share by Type (2015-2020)
Table 36. Americas Influenza Vaccine Consumption by Application (2015-2020) (K Doses)
Table 37. Americas Influenza Vaccine Consumption Market Share by Application (2015-2020)
Table 38. APAC Influenza Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 39. APAC Influenza Vaccine Consumption Market Share by Countries (2015-2020)
Table 40. APAC Influenza Vaccine Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Influenza Vaccine Value Market Share by Regions (2015-2020)
Table 42. APAC Influenza Vaccine Consumption by Type (2015-2020) (K Doses)
Table 43. APAC Influenza Vaccine Consumption Market Share by Type (2015-2020)
Table 44. APAC Influenza Vaccine Consumption by Application (2015-2020) (K Doses)
Table 45. APAC Influenza Vaccine Consumption Market Share by Application (2015-2020)
Table 46. Europe Influenza Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 47. Europe Influenza Vaccine Consumption Market Share by Countries (2015-2020)
Table 48. Europe Influenza Vaccine Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Influenza Vaccine Value Market Share by Countries (2015-2020)
Table 50. Europe Influenza Vaccine Consumption by Type (2015-2020) (K Doses)
Table 51. Europe Influenza Vaccine Consumption Market Share by Type (2015-2020)
Table 52. Europe Influenza Vaccine Consumption by Application (2015-2020) (K Doses)
Table 53. Europe Influenza Vaccine Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Influenza Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 55. Middle East & Africa Influenza Vaccine Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Influenza Vaccine Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Influenza Vaccine Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Influenza Vaccine Consumption by Type (2015-2020) (K Doses)
Table 59. Middle East & Africa Influenza Vaccine Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Influenza Vaccine Consumption by Application (2015-2020) (K Doses)
Table 61. Middle East & Africa Influenza Vaccine Consumption Market Share by Application (2015-2020)
Table 62. Influenza Vaccine Distributors List
Table 63. Influenza Vaccine Customer List
Table 64. Global Influenza Vaccine Consumption Forecast by Countries (2021-2025) (K Doses)
Table 65. Global Influenza Vaccine Consumption Market Forecast by Regions
Table 66. Global Influenza Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Influenza Vaccine Value Market Share Forecast by Regions
Table 68. Global Influenza Vaccine Consumption Forecast by Type (2021-2025) (K Doses)
Table 69. Global Influenza Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Influenza Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Influenza Vaccine Value Market Share Forecast by Type (2021-2025)
Table 72. Global Influenza Vaccine Consumption Forecast by Application (2021-2025) (K Doses)
Table 73. Global Influenza Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Influenza Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Influenza Vaccine Value Market Share Forecast by Application (2021-2025)
Table 76. CSL Product Offered
Table 77. CSL Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 78. CSL Main Business
Table 79. CSL Latest Developments
Table 80. CSL Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Product Offered
Table 82. GSK Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. GSK Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Mylan Product Offered
Table 87. Mylan Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 88. Mylan Main Business
Table 89. Mylan Latest Developments
Table 90. Mylan Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. AstraZeneca Product Offered
Table 92. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 93. AstraZeneca Main Business
Table 94. AstraZeneca Latest Developments
Table 95. AstraZeneca Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Sanofi Pasteur Product Offered
Table 97. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 98. Sanofi Pasteur Main Business
Table 99. Sanofi Pasteur Latest Developments
Table 100. Sanofi Pasteur Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Pfizer Product Offered
Table 102. Pfizer Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)
Table 103. Pfizer Main Business
Table 104. Pfizer Latest Developments
Table 105. Pfizer Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Johnson & Johnson Product Offered
Table 107. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Main Business
Table 109. Johnson & Johnson Latest Developments
Table 110. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E)

List of Figures

Figure 1. Picture of Influenza Vaccine
Figure 2. Influenza Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Influenza Vaccine Consumption Growth Rate 2015-2025 (K Doses)
Figure 5. Global Influenza Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Whole Virus Vaccines
Figure 7. Product Picture of Split Virus Vaccines
Figure 8. Product Picture of Subunit Vaccines
Figure 9. Product Picture of Live Attenuated Virus Vaccines
Figure 10. Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
Figure 11. Global Influenza Vaccine Value Market Share by Type (2015-2020)
Figure 12. Influenza Vaccine Consumed in For Children (6 months to 3 years)
Figure 13. Global Influenza Vaccine Market: For Children (6 months to 3 years) (2015-2020) (K Doses)
Figure 14. Global Influenza Vaccine Market: For Children (6 months to 3 years) (2015-2020) ($ Millions)
Figure 15. Influenza Vaccine Consumed in For Adults and Children over 3 years
Figure 16. Global Influenza Vaccine Market: For Adults and Children over 3 years (2015-2020) (K Doses)
Figure 17. Global Influenza Vaccine Market: For Adults and Children over 3 years (2015-2020) ($ Millions)
Figure 18. Global Influenza Vaccine Consumption Market Share by Application (2015-2020)
Figure 19. Global Influenza Vaccine Value Market Share by Application (2015-2020)
Figure 20. Global Influenza Vaccine Sales Market Share by Company in 2017
Figure 21. Global Influenza Vaccine Sales Market Share by Company in 2019
Figure 22. Global Influenza Vaccine Revenue Market Share by Company in 2017
Figure 23. Global Influenza Vaccine Revenue Market Share by Company in 2019
Figure 24. Global Influenza Vaccine Sale Price by Company in 2019
Figure 25. Global Influenza Vaccine Consumption Market Share by Regions 2015-2020
Figure 26. Global Influenza Vaccine Value Market Share by Regions 2015-2020
Figure 27. Americas Influenza Vaccine Consumption 2015-2020 (K Doses)
Figure 28. Americas Influenza Vaccine Value 2015-2020 ($ Millions)
Figure 29. APAC Influenza Vaccine Consumption 2015-2020 (K Doses)
Figure 30. APAC Influenza Vaccine Value 2015-2020 ($ Millions)
Figure 31. Europe Influenza Vaccine Consumption 2015-2020 (K Doses)
Figure 32. Europe Influenza Vaccine Value 2015-2020 ($ Millions)
Figure 33. Middle East & Africa Influenza Vaccine Consumption 2015-2020 (K Doses)
Figure 34. Middle East & Africa Influenza Vaccine Value 2015-2020 ($ Millions)
Figure 35. Americas Influenza Vaccine Consumption Market Share by Countries in 2019
Figure 36. Americas Influenza Vaccine Value Market Share by Countries in 2019
Figure 37. Americas Influenza Vaccine Consumption Market Share by Type in 2019
Figure 38. Americas Influenza Vaccine Consumption Market Share by Application in 2019
Figure 39. United States Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 40. United States Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 41. Canada Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 42. Canada Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 43. Mexico Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 44. Mexico Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 45. APAC Influenza Vaccine Consumption Market Share by Countries in 2019
Figure 46. APAC Influenza Vaccine Value Market Share by Regions in 2019
Figure 47. APAC Influenza Vaccine Consumption Market Share by Type in 2019
Figure 48. APAC Influenza Vaccine Consumption Market Share by Application in 2019
Figure 49. China Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 50. China Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. Japan Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 52. Japan Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 53. Korea Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 54. Korea Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 55. Southeast Asia Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 56. Southeast Asia Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. India Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 58. India Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Australia Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 60. Australia Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 61. Europe Influenza Vaccine Consumption Market Share by Countries in 2019
Figure 62. Europe Influenza Vaccine Value Market Share by Countries in 2019
Figure 63. Europe Influenza Vaccine Consumption Market Share by Type in 2019
Figure 64. Europe Influenza Vaccine Consumption Market Share by Application in 2019
Figure 65. Germany Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 66. Germany Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. France Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 68. France Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 69. UK Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 70. UK Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 71. Italy Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 72. Italy Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. Russia Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 74. Russia Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 75. Middle East & Africa Influenza Vaccine Consumption Market Share by Countries in 2019
Figure 76. Middle East & Africa Influenza Vaccine Value Market Share by Countries in 2019
Figure 77. Middle East & Africa Influenza Vaccine Consumption Market Share by Type in 2019
Figure 78. Middle East & Africa Influenza Vaccine Consumption Market Share by Application in 2019
Figure 79. Egypt Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 80. Egypt Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. South Africa Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 82. South Africa Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 83. Israel Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 84. Israel Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 85. Turkey Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 86. Turkey Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 87. GCC Countries Influenza Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 88. GCC Countries Influenza Vaccine Value Growth 2015-2020 ($ Millions)
Figure 89. Global Influenza Vaccine Consumption Growth Rate Forecast (2021-2025) (K Doses)
Figure 90. Global Influenza Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 91. Americas Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 92. Americas Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 93. APAC Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 94. APAC Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 95. Europe Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 96. Europe Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 97. Middle East & Africa Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 98. Middle East & Africa Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 99. United States Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 100. United States Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 101. Canada Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 102. Canada Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 103. Mexico Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 104. Mexico Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 105. Brazil Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 106. Brazil Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 107. China Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 108. China Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 109. Japan Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 110. Japan Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 111. Korea Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 112. Korea Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 113. Southeast Asia Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 114. Southeast Asia Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 115. India Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 116. India Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 117. Australia Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 118. Australia Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 119. Germany Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 120. Germany Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 121. France Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 122. France Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 123. UK Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 124. UK Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 125. Italy Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 126. Italy Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 127. Russia Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 128. Russia Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 129. Spain Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 130. Spain Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 131. Egypt Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 132. Egypt Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 133. South Africa Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 134. South Africa Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 135. Israel Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 136. Israel Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 137. Turkey Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 138. Turkey Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 139. GCC Countries Influenza Vaccine Consumption 2021-2025 (K Doses)
Figure 140. GCC Countries Influenza Vaccine Value 2021-2025 ($ Millions)
Figure 141. CSL Influenza Vaccine Market Share (2018-2020)
Figure 142. GSK Influenza Vaccine Market Share (2018-2020)
Figure 143. Mylan Influenza Vaccine Market Share (2018-2020)
Figure 144. AstraZeneca Influenza Vaccine Market Share (2018-2020)
Figure 145. Sanofi Pasteur Influenza Vaccine Market Share (2018-2020)
Figure 146. Pfizer Influenza Vaccine Market Share (2018-2020)
Figure 147. Johnson & Johnson Influenza Vaccine Market Share (2018-2020)
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs